Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial | Annals of the Rheumatic Diseases
Long-Term Safety of Adalimumab (HUMIRA) in Adult Patients from Global Clinical Trials across Multiple Indications: An Updated Analysis in 29,987 Patients Representing 56,951 Patient-Years - ACR Meeting Abstracts
Frontiers | Clinical Evaluation of Humira® Biosimilar ONS-3010 in Healthy Volunteers: Focus on Pharmacokinetics and Pharmacodynamics
Adalimumab: a review of the reference product and biosimilars | BS
Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet's disease: results from a large real-world observational study
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis - Gastroenterology
A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis | Arthritis Research & Therapy | Full Text
Crohn's Remission and Results With HUMIRA® (adalimumab)
Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III - Ophthalmology
Long-term data on the proposed adalimumab biosimilar BCD-057 in patients with moderate to severe psoriasis: A randomized controlled trial | PLOS ONE
Frontiers | Head-to-Head Comparison of Etanercept vs. Adalimumab in the Treatment of Ankylosing Spondylitis: An Open-Label Randomized Controlled Crossover Clinical Trial
Humira, INN - adalimumab
HUMIRA (adalimumab) Hidradenitis Suppurativa Clinical Data
Adalimumab: a review of the reference product and biosimilars | BS
Bimekizumab versus Adalimumab in Plaque Psoriasis | NEJM
A randomised double-blind placebo-controlled crossover trial of HUMira ( adalimumab) for erosive hand OsteoaRthritis – the HUMOR trial - Osteoarthritis and Cartilage
JPM | Free Full-Text | Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis | HTML
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial
Comparison of effect sizes between the efficacy of treatment with... | Download Scientific Diagram
Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial - The Lancet Gastroenterology & Hepatology
HUMIRA (adalimumab), Abbott Laboratories - Package Insert
Humira 40 mg/0.4 ml Pre-filled Syringe and Pre-filled Pen (Great Britain) - Summary of Product Characteristics (SmPC) - (emc)
HUMIRA (adalimumab) Dermatology HCP Site
Humira, INN - adalimumab
